© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
December 14, 2013
The American Journal of Pharmacy Benefits
We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
December 13, 2013
Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Today's youth risk becoming the first generation not to outlive their parents. It is not too late, however, to halt and reverse this trend.
December 12, 2013
It is now time for health plans and employers to create a consumer-focused benefit.
December 11, 2013
A major opportunity to improve patient outcomes and organizational finances exists in the pharmacy service line.